MWP
WST icon

Meridian Wealth Partners’s West Pharmaceutical WST Stock Holding History

Meridian Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24
Closed -$7K – 1283
2021
Q1 		$7K Buy
+24
New +$6.87K ﹤0.01% 590

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Meridian Wealth Partners's WST Position: Q2 2021 in Review

Meridian Wealth Partners sold out of West Pharmaceutical (WST) in Q2 2021, closing a stake of 24 shares — an estimated $7K sold.

Meridian Wealth Partners first reported a position in WST in Q1 2021 and held it in 1 quarter. The position peaked at $7K in Q1 2021. 640 funds tracked by Wall St. Rank hold WST as of Q2 2021.

  • Meridian Wealth Partners reported no remaining West Pharmaceutical position as of Q2 2021 after selling out during the quarter.
  • Meridian Wealth Partners sold 24 West Pharmaceutical shares in Q2 2021, an estimated $7K.
  • Meridian Wealth Partners first reported a position in West Pharmaceutical in Q1 2021 and held it in 1 quarter.
  • Meridian Wealth Partners's West Pharmaceutical position peaked at $7K in Q1 2021.
  • 640 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.